BAVENCIO® (avelumab) PATIENT ASSISTANCE PROGRAM

CoverOne includes a patient assistance program that provides BAVENCIO® (avelumab) at no charge for patients who meet certain income, insurance (i.e. uninsured), and residency eligibility criteria.

  • To determine patient eligibility, providers should complete and submit the CoverOne BAVENCIO Enrollment Form prior to treatment. Patient assistance is not applied retroactively.
  • A CoverOne representative will notify you as soon as possible with the patient's eligibility determination.

Please include the most recent tax return (e.g., IRS Form 1040) if applying for the Patient Assistance Program.

 

NOTE: The CoverOne patient assistance program is a philanthropic program for patients in need, and is not contingent on any past or future commercial sale.

©2025 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne  are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.

COOKIE SETTINGS

US-MULO-00131     03/25

©2025 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne  are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.

COOKIE SETTINGS

US-MULO-00131     03/25

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

You are about to leave the CoverOne website and are being redirected to a non-CoverOne website. EMD Serono does not review nor control the content of the following website. This redirection does not constitute an endorsement by EMD Serono of the following organization or any information provided by the organization.

Continue